List view / Grid view
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
HIV is a disease still common in sub-Saharan Africa despite global research since 1982. This article delves into the trends, opportunities and key players in HIV research, exploring future possibilities for treating the disease.
The new screening technique may enable development of novel combination-immunotherapy regimens against cancers and persistent infections.
A study conducted on human pancreatic tumours transplanted in mice reveals promise for an effective therapy in the future, say researchers.
A library of products derived from more than 10,000 fungi has been established which could lead to the discovery of new drugs.
Using absorbance microplate readers to streamline beer, wine and food safety analyses using industry-standard approved methods.
Research has found that artificial intelligence in drug discovery will be worth $1,434 million by the end of 2024.
On 5-6 November, ACC Liverpool hosted the ELRIG Drug Discovery event, which allowed R&D professionals to come together and discuss the latest industry developments.
A new antiviral drug has been reported in a study that researchers believe has high clinical potential as a next-generation influenza drug.
A machine-learning algorithm has been created that automates high-throughput screens of epigenetic medicines.
22 October 2019 | By Halo Labs
Aqueous solubility of small molecule compounds is an essential parameter during the hit-to-lead stage of drug discovery as well as lead optimization and formulation. Low solubility can result in misleading ADMET/DMPK analyses if some fraction of a compound precipitates. Watch on-demand to find out more!
A drug discovery platform for mental health treatment could also help to identify mechanisms for the treatment of substance use disorders.
New protein-painting technology could lead to developing cancer immunotherapy medicines that can be administered as a pill.
Researchers have imaged an inflammation-related protein receptor on cell membranes which could inform future drug designs to prevent cell death.
A new process for identifying and biosynthesising drug candidates has been discovered by researchers at the Carl R Woese Institute for Genomic Biology.
The process that bacteria use to defend themselves has been revealed by researchers, who also demonstrated how to activate the process.
